RECURRENT BREAST ADENOCARCINOMA

Clinical trials for RECURRENT BREAST ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT BREAST ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for RECURRENT BREAST ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Major trial tests new weapon against spreading breast cancer

Disease control Completed

This large, completed study tested whether adding an immunotherapy drug (atezolizumab) to a standard three-drug combination could better control advanced HER2-positive breast cancer that had spread. It involved 190 patients who were randomly assigned to receive either the new fou…

Matched conditions: RECURRENT BREAST ADENOCARCINOMA

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

RECURRENT BREAST ADENOCARCINOMA

Get alerted when new RECURRENT BREAST ADENOCARCINOMA trials appear

Major trial tests new weapon against spreading breast cancer